Barlow Carrolee 4
4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 24, 2025
Insider Transaction Report
Form 4
Barlow Carrolee
Director
Transactions
- Award
Common Stock
2025-02-22+5,369→ 22,570 total - Disposition to Issuer
Restricted Stock Units
2025-02-22−5,369→ 0 total→ Common Stock (5,369 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
- [F2]These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2025.